Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Drug Resistance

Free Subscription Articles published in J Antimicrob Chemother Retrieve available abstracts of 290 articles: HTML format

Single Articles

October 2025
1. CHOWDHURY FR, Findlay BL
   Sequential antibiotic exposure restores antibiotic susceptibility.
   J Antimicrob Chemother. 2025 Oct 8:dkaf350. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. LAI CC, Liu CY, Huang KJ, Huang YT, et al
   Global susceptibility profiles and potential resistance mechanisms of ceftazidime-avibactam-resistant, non-carbapenemase-producing carbapenem-resistant Enterobacterales: 2020-23 data from the Antimicrobial Testing Leadership and Surveillance.
   J Antimicrob Chemother. 2025 Oct 7:dkaf375. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. HSU CH, Li C, Harrison L, Zhao S, et al
   Genomic structure of class 1 and 2 integrons in non-typhoidal Salmonella isolated from food animals and related meat products in the USA.
   J Antimicrob Chemother. 2025;80:2844-2853.
   PubMed     Abstract available
   
   
   
4. YANG J, Jiang T, Zhang M, Xue J, et al
   Phenotypic and genotypic profiles of clinical isolates of various Nocardia species to carbapenems and fluoroquinolones.
   J Antimicrob Chemother. 2025;80:2862-2872.
   PubMed     Abstract available
   
   
   
5. LARKIN C, Valappil SP, Palanisamy N
   Global prevalence of nitrofurantoin-resistant uropathogenic Escherichia coli (UPEC) in humans: a systematic review and meta-analysis.
   J Antimicrob Chemother. 2025;80:2609-2621.
   PubMed     Abstract available
   
   
   
6. HALIM J, Keane AP, Bouzo J, Aderibigbe T, et al
   Synergistic cefiderocol-containing antibiotic combinations active against highly drug-resistant Acinetobacter baumannii patient isolates with diverse resistance mechanisms.
   J Antimicrob Chemother. 2025;80:2814-2824.
   PubMed     Abstract available
   
   
   
7. ZAGHI I, Cricca M, Roberts JA, Brandolini M, et al
   Development of blood culture time-to-positivity as a pharmacodynamic indicator for monitoring antibiotic therapy against MDR Gram-negative bacteria.
   J Antimicrob Chemother. 2025;80:2705-2713.
   PubMed     Abstract available
   
   
   
8. SKOVMAND S, Norgaard C, Salado-Rasmussen K, Jensen JS, et al
   In vitro activity of thiamphenicol against drug-susceptible and drug-resistant strains of Mycoplasma genitalium.
   J Antimicrob Chemother. 2025;80:2676-2681.
   PubMed     Abstract available
   
   
   September 2025
9. CINCOTTA SE, Ostrowsky BE, Howard-Anderson J, Beekmann SE, et al
   Treatment preferences by infectious diseases clinicians for carbapenem-resistant Enterobacterales infections.
   J Antimicrob Chemother. 2025 Sep 30:dkaf371. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. IACHKINE J, Alexandre K, Marlat C, Briant A, et al
    Temocillin versus other intravenous beta-lactams for urinary tract infections caused by third-generation cephalosporin-resistant Enterobacterales: a multicentre retrospective matched cohort study.
    J Antimicrob Chemother. 2025 Sep 30:dkaf370. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. GIARRATANA LR, Pirolo M, Roch FF, Conrady B, et al
    Evolving landscape of methicillin-resistant Staphylococcus pseudintermedius: the emergence of new epidemic waves across Europe, Asia and North America.
    J Antimicrob Chemother. 2025 Sep 27:dkaf340. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. WITKOWSKA A, Biedrzycka M, Izdebski R, Literacka E, et al
    Assessment of an LC coupled with tandem MS (LC-MS/MS) tool in the detection of antimicrobial resistance mechanisms in Enterobacterales.
    J Antimicrob Chemother. 2025 Sep 24:dkaf339. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. XU W, Yan P, Li Y, Sun B, et al
    The toxin-antitoxin system SavRS contributes to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus by mediating cell wall thickening.
    J Antimicrob Chemother. 2025 Sep 23:dkaf325. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. ELADAWY M, Heslop N, Negus D, Thomas JC, et al
    Phenotype-genotype discordance in antimicrobial resistance profiles of Gram-negative uropathogens recovered from catheter-associated urinary tract infections in Egypt.
    J Antimicrob Chemother. 2025 Sep 23:dkaf352. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. ZHU Y, Du S, Schwarz S, Hou J, et al
    Co-existence of the oxazolidinone resistance genes cfr and optrA on a novel multiresistance plasmid from a methicillin-resistant Macrococcoides bohemicum strain.
    J Antimicrob Chemother. 2025 Sep 22:dkaf333. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. YANG P, Liu C, Zheng J, Yi J, et al
    Rapid replacement of blaKPC variant in ST11 carbapenem-resistant and hypervirulent Klebsiella pneumoniae contributed to ceftazidime/avibactam resistance during severe in vivo infection.
    J Antimicrob Chemother. 2025 Sep 18:dkaf337. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. PAPAIOANNU BORJESSON R, Diotallevi S, Lolatto R, Cenderello G, et al
    Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era.
    J Antimicrob Chemother. 2025;80:2369-2374.
    PubMed     Abstract available
    
    
    
18. POCIUPANY M, Gillemot S, Georgala A, Snoeck R, et al
    Dynamics of dual CMV and EBV co-reactivation and emergence of resistance in an HSCT recipient.
    J Antimicrob Chemother. 2025;80:2474-2483.
    PubMed     Abstract available
    
    
    
19. NAIR S, Barker CR, Patel V, Poh CY, et al
    Highly drug-resistant Vibrio cholerae harbouring blaPER-7 isolated from travellers returning to England.
    J Antimicrob Chemother. 2025;80:2428-2432.
    PubMed     Abstract available
    
    
    
20. LIU J, Yang X, Deng X, Hou M, et al
    Transmitted drug resistance profiles among people living with HIV-1 in Henan province, China, 2024.
    J Antimicrob Chemother. 2025;80:2496-2502.
    PubMed     Abstract available
    
    
    
21. IMOLI D, Maingi JM, Mbae C, Kavai SM, et al
    Genomic characterization of multidrug-resistant extended-spectrum beta-lactamase-producing Vibrio cholerae O1 strains from 2022 cholera outbreak in Kenya.
    J Antimicrob Chemother. 2025;80:2399-2407.
    PubMed     Abstract available
    
    
    August 2025
22. HAO J, Lu F, Chen P, Ji C, et al
    Characterization of blaOXA-542-mediated carbapenem resistance in Acinetobacter baumannii.
    J Antimicrob Chemother. 2025 Aug 29:dkaf311. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. LI J, Hou W, Chang J, Tian X, et al
    The pivotal role of acnA in linking carbon metabolism to virulence and antimicrobial resistance in methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2025 Aug 28:dkaf317. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. MCCRACKEN M, Walkty A, Adam HJ, Baxter M, et al
    Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23).
    J Antimicrob Chemother. 2025;80.
    PubMed     Abstract available
    
    
    
25. MATASEJE LF, Lerminiaux N, Lagace-Wiens P, Walkty A, et al
    Characterization of ertapenem-resistant Enterobacterales in Canadian hospitals: 17 years of the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    PubMed     Abstract available
    
    
    
26. ADAM HJ, Golden AR, Martin I, Baxter MR, et al
    Comparison of antimicrobial resistance and serotype patterns in Streptococcus pneumoniae from blood cultures and respiratory specimens in Canadian hospitals from the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    PubMed     Abstract available
    
    
    
27. BRAHAMI A, Karlowsky JA, McCracken M, Golding GR, et al
    Characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 17 years of the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    PubMed     Abstract available
    
    
    
28. ZHANEL GG, Baxter MR, Lagace-Wiens P, Walkty A, et al
    Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    PubMed     Abstract available
    
    
    
29. ZHANEL GG, Baxter MR, Golden AR, Lagace-Wiens P, et al
    Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    PubMed     Abstract available
    
    
    
30. LAGACE-WIENS P, Mataseje L, McCracken M, Walkty A, et al
    Increasing rates of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Canadian Hospitals: 17 years of the CANWARD study, 2007-23.
    J Antimicrob Chemother. 2025;80.
    PubMed     Abstract available
    
    
    
31. HURLEY JC, Madec JY
    The CANWARD studies: Canadian Antimicrobial Resistance Alliance (CARA) Canadian Hospital Ward Antibiotic Resistance Surveillance collection.
    J Antimicrob Chemother. 2025;80.
    PubMed    
    
    
    
32. SUN Y, McGiffin D, Ye L, Kostoulias X, et al
    Low bacterial metabolism as a central mechanism of antimicrobial resistance and potential therapeutic target of staphylococcal biofilms in ventricular assist device driveline infections.
    J Antimicrob Chemother. 2025 Aug 26:dkaf316. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. CERCENADO E, Marin M, Iglesias M, Jimenez L, et al
    Molecular characterization of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae susceptible to delafloxacin.
    J Antimicrob Chemother. 2025 Aug 21:dkaf308. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. MANCINI S, Seth-Smith HMB, Kolesnik-Goldmann N, Mermod M, et al
    Performance of disc diffusion and gradient strip test on different Mueller-Hinton agar media plates and ComASP(R) and Bruker UMIC(R) Cefiderocol Microdilution Panels for cefiderocol susceptibility testing in carbapenem-resistant Pseudomonas aeruginosa
    J Antimicrob Chemother. 2025 Aug 18:dkaf301. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. ZENG Q, Huang H, Lu J, Wu L, et al
    Comparative outcomes of polymyxins in neurocritical care patients with carbapenem-resistant Gram-negative bacterial pneumonia: a retrospective cohort study.
    J Antimicrob Chemother. 2025 Aug 7:dkaf295. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. BALAKUNTLA J, Simjee S, Mane SP, Tice G, et al
    Distinct population structure and genomic context of NarAB between broiler and human clinical Enterococcus isolates.
    J Antimicrob Chemother. 2025 Aug 7:dkaf296. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. ANASTASSOPOULOU C, Panagiotopoulos AP, Ferous S, Tsakris A, et al
    Phages connect the biological dots of antimicrobial resistance: from genesis and spread to alternative treatment modules.
    J Antimicrob Chemother. 2025 Aug 6:dkaf293. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. GAGLIARDINI R, De Benedittis S, Tavelli A, Lapadula G, et al
    Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort.
    J Antimicrob Chemother. 2025;80:2169-2178.
    PubMed     Abstract available
    
    
    
39. BRENCIANI A, Massacci FR, Albini E, Cucco L, et al
    Novel integrative and conjugative elements carrying cfr(B) and cfr(C) linezolid resistance genes in Clostridioides difficile isolates from calves, Italy.
    J Antimicrob Chemother. 2025;80:2280-2284.
    PubMed     Abstract available
    
    
    
40. SADER HS, Kimbrough JH, Winkler ML, Castanheira M, et al
    Aztreonam/avibactam activity against Enterobacterales from European medical centres: summary of 5 years of surveillance prior to approval for clinical use (2019-2023).
    J Antimicrob Chemother. 2025;80:2070-2079.
    PubMed     Abstract available
    
    
    
41. WATERA C, Da Silva JF, Namayanja G, Asio JN, et al
    HIV-1 drug resistance among people living with HIV receiving dolutegravir-based anti-retroviral regimens in Uganda: a national laboratory-based survey using remnant viral load samples, 2022.
    J Antimicrob Chemother. 2025;80:2126-2134.
    PubMed     Abstract available
    
    
    July 2025
42. FERRANDO ML, Saluzzo F, Frederiksen RF, Slettemeas JS, et al
    Determination of epidemiological cut-off values for Narasin, Salinomycin, Lasalocid and Monensin in Enterococcus faecium.
    J Antimicrob Chemother. 2025 Jul 31:dkaf113. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. ABEGAZ FA, Al-Mir H, Kostyanev T, Prifti K, et al
    Strengthening antimicrobial resistance diagnostics in National Reference Laboratories across One Health in South and Southeast Asia: impact of external quality assessment and targeted follow-up.
    J Antimicrob Chemother. 2025 Jul 29:dkaf266. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. CHEN X, Ouyang F, Wang N, Liu D, et al
    Synergistic effects of DHA27 combined with gentamicin against methicillin-resistant Staphylococcus aureus in vitro and in vivo.
    J Antimicrob Chemother. 2025 Jul 25:dkaf239. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. NODA M, Furuta A, Yashima S, Yaguchi D, et al
    Fluctuations in copy number of the class A carbapenemase gene blaFRI appear to confer high-level carbapenem resistance.
    J Antimicrob Chemother. 2025 Jul 25:dkaf258. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. DEL MONTE M, Kaleci S, Chester J, Zerbato V, et al
    Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study.
    J Antimicrob Chemother. 2025 Jul 22:dkaf242. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. OU TH, Yang JL, Lin CY, Huang SH, et al
    Impact of empiric anti-VRE therapy on survival in vancomycin-resistant enterococcal bloodstream infection.
    J Antimicrob Chemother. 2025 Jul 17:dkaf225. doi: 10.1093.
    PubMed     Abstract available
    
    
    
48. SINGH S, Adhikari S, Varshney N, Rani C, et al
    Overcoming antimicrobial resistance in Helicobacter pylori: the roles of collateral sensitivity and biofilm dynamics.
    J Antimicrob Chemother. 2025 Jul 15:dkaf233. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. MORAN RA, Hall RM
    The catA1 chloramphenicol resistance gene originated in Atlantibacter hermannii.
    J Antimicrob Chemother. 2025 Jul 11:dkaf227. doi: 10.1093.
    PubMed    
    
    
    
50. VAN DEN BIGGELAAR RHGA, Erdkamp D, de Visser AW, van den Eeden SJF, et al
    Indolocarbazoles as host-directed therapeutics against intracellular infections by methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2025 Jul 1:dkaf198. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. CHUA TP, Danielewski J, Bradshaw CS, Machalek DA, et al
    A novel azithromycin resistance mutation in Mycoplasma genitalium induced in vitro.
    J Antimicrob Chemother. 2025;80:2044-2050.
    PubMed     Abstract available
    
    
    
52. PARANOS P, Siopi M, Papanikolaou E, Vourli S, et al
    Reversal of phenotypic resistance in multi-drug resistant carbapenemase-producing K. pneumoniae clinical isolates due to in vitro synergistic interactions between bacteriophages and antibiotics at clinically achievable concentrations.
    J Antimicrob Chemother. 2025;80:1997-2006.
    PubMed     Abstract available
    
    
    
53. LUO Z, Ning Y, Xiao M, Guo D, et al
    High azole non-wild type rates and nosocomial microsatellite typing aggregation of Wickerhamomyces anomalus in China according to a 12-year multicenter surveillance study.
    J Antimicrob Chemother. 2025;80:1964-1971.
    PubMed     Abstract available
    
    
    
54. ZHAN Z, Cui Y, He S, Chang J, et al
    Molecular characteristics of chromosome-mediated colistin resistance in foodborne Salmonella isolates in China.
    J Antimicrob Chemother. 2025;80:1951-1963.
    PubMed     Abstract available
    
    
    
55. KOONG J, Hall RM, Hamidian M
    Genomic characteristics of the multiresistant Acinetobacter baumannii global clone 1 reference strain A297/RUH875.
    J Antimicrob Chemother. 2025;80:1988-1992.
    PubMed     Abstract available
    
    
    
56. ATTWOOD MLG, Noel A, Griffin P, Racine E, et al
    In vitro activity of NOSO-502, a novel-action antimicrobial, against clinical strains of Enterobacterales including MDR strains.
    J Antimicrob Chemother. 2025;80:1942-1946.
    PubMed     Abstract available
    
    
    
57. DAVIDSON HC, Yau T, Dunstan I, Houston A, et al
    Early use of the novel antifungal rezafungin: a case series and literature review.
    J Antimicrob Chemother. 2025;80:1885-1892.
    PubMed     Abstract available
    
    
    June 2025
58. LI J, He J, Huang Q
    Comment on: Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital.
    J Antimicrob Chemother. 2025 Jun 27:dkaf200. doi: 10.1093.
    PubMed    
    
    
    
59. QIU X, Tang J, Zhou J, Zhao X, et al
    Novel tmexC7D2-toprJ5 gene cluster and transposon Tn7759 carrying blaVIM-2 and blaOXA-10 genes in a carbapenem-resistant Pseudomonas putida from urban sewage.
    J Antimicrob Chemother. 2025 Jun 25:dkaf203. doi: 10.1093.
    PubMed    
    
    
    
60. AVCU G
    Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a Tertiary University Hospital-right to reply-author's response.
    J Antimicrob Chemother. 2025 Jun 25:dkaf201. doi: 10.1093.
    PubMed    
    
    
    
61. HONDA T, Vazquez-Montes MDLA, Fanshawe TR, Stoesser N, et al
    The impact of inter-infection time on antimicrobial resistance profiles in women with multiple urinary tract infections over time.
    J Antimicrob Chemother. 2025 Jun 24:dkaf194. doi: 10.1093.
    PubMed     Abstract available
    
    
    
62. RASMUSSEN A, Hammerum AM, Hansen F, Soes LM, et al
    Carbapenem resistance in Escherichia marmotae: characterization of IncL plasmids carrying blaOXA-48.
    J Antimicrob Chemother. 2025 Jun 16:dkaf188. doi: 10.1093.
    PubMed    
    
    
    
63. ZHENG YD, Xu J, Wu J, Zhong T, et al
    Oleanolic acid derivative bardoxolone combats multidrug-resistant Staphylococcus aureus by destroying cell membrane and pyruvate metabolism pathway.
    J Antimicrob Chemother. 2025 Jun 10:dkaf190. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. KIHLBERG P, Bech Johannesen T, Stegger M, Cajander S, et al
    Reliability of disc diffusion testing and molecular epidemiology of penicillin-susceptible Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2025 Jun 10:dkaf187. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. EL NAGAR A, Dewe TCM, Broadfoot F, Teale C, et al
    Decreasing antimicrobial resistance in representative UK livestock species was associated with reduced total sales of antimicrobials in the last decade.
    J Antimicrob Chemother. 2025 Jun 5:dkaf145. doi: 10.1093.
    PubMed     Abstract available
    
    
    
66. EDSLEV SM, Laurent F, Mansson E, Johannesen TB, et al
    Antibiotic resistance and population structure of Staphylococcus epidermidis from prosthetic joint infections in Sweden and France.
    J Antimicrob Chemother. 2025 Jun 3:dkaf166. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. RUGEMALILA J, Ndege R, Kunambi P, Shabani S, et al
    Viral suppression after failure of PI-based ART among adolescents and youths with and without drug resistance mutations: a longitudinal analysis in Tanzania.
    J Antimicrob Chemother. 2025;80:1694-1701.
    PubMed     Abstract available
    
    
    
68. HANDAL N, Kaspersen H, Mo SS, Cabanel N, et al
    A comparative study of the molecular characteristics of human uropathogenic Escherichia coli collected from two hospitals in Norway and France in 2019.
    J Antimicrob Chemother. 2025;80:1707-1715.
    PubMed     Abstract available
    
    
    
69. ZHANG BL, Li H, Wang WX, Chen XZ, et al
    Depolymerase as a potent adjunct to polymyxin for targeting KL160 pandrug-resistant Acinetobacter baumannii in a murine bacteremia model.
    J Antimicrob Chemother. 2025;80:1613-1625.
    PubMed     Abstract available
    
    
    
70. HAMZE H, Payne M, Stefanovic A, Lowe CF, et al
    Helicobacter pylori culture positivity and antimicrobial susceptibility profiles (Vancouver, Canada).
    J Antimicrob Chemother. 2025;80:1640-1646.
    PubMed     Abstract available
    
    
    
71. RIPAMONTI D, Comi L, Francavilla A, Valenti D, et al
    Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study).
    J Antimicrob Chemother. 2025;80:1665-1672.
    PubMed     Abstract available
    
    
    
72. LIN D, Zhang Y, Luo Z, Wang J, et al
    Unravelling the genetic contributors to linezolid resistance in Mycobacterium smegmatis: insights from a transposon library.
    J Antimicrob Chemother. 2025;80:1595-1603.
    PubMed     Abstract available
    
    
    
73. SARIA P, Doulidis PG, Desvars-Larrive A, Toth AG, et al
    Pandemic human-associated extended-spectrum beta-lactamase-producing Escherichia coli lineages of ST38, ST131 and ST141 identified in Viennese dogs.
    J Antimicrob Chemother. 2025;80:1573-1576.
    PubMed     Abstract available
    
    
    May 2025
74. CHO H, Park KT
    A novel methicillin-resistant Staphylococcus aureus lineage (ST4174) with an uncharacterized SCCmec variant identified in Korean pigs.
    J Antimicrob Chemother. 2025 May 31:dkaf178. doi: 10.1093.
    PubMed    
    
    
    
75. CANAS MA, Garcia-de-la-Maria C, Garcia-Gonzalez J, Jimenez MP, et al
    Efficacy of linezolid in monotherapy q12h versus q8h versus combined with daptomycin in the treatment of experimental endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus strains.
    J Antimicrob Chemother. 2025 May 27:dkaf149. doi: 10.1093.
    PubMed     Abstract available
    
    
    
76. KRISHNAPRASAD VH, Nayak V, Kumar S
    World Health Organisation's Bacterial Pathogen Priority List (BPPL) 2017 and BPPL 2024 to combat global antimicrobial resistance crisis: 'challenges and opportunities'.
    J Antimicrob Chemother. 2025 May 27:dkaf167. doi: 10.1093.
    PubMed     Abstract available
    
    
    
77. HTAIK K, Vodstrcil LA, Plummer EL, Matthews LG, et al
    Efficacy and tolerability of the combination of minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium.
    J Antimicrob Chemother. 2025 May 22:dkaf142. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. BUTSCHEID Y, Frey PM, Pfister M, Pagani L, et al
    Decline of antimicrobial resistance in Pseudomonas aeruginosa bacteraemia following the COVID-19 pandemic: a longitudinal observational study.
    J Antimicrob Chemother. 2025 May 14:dkaf136. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. VERA-YUNCA D, Matias C, Vingsbo Lundberg C, Friberg LE, et al
    Model-based translation of the PKPD-relationship for linezolid and vancomycin on methicillin-resistant Staphylococcus aureus: from in vitro time-kill experiments to a mouse pneumonia model.
    J Antimicrob Chemother. 2025 May 9:dkaf140. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. SINGH R, Mukherjee S, Harrision LB, McDermott PF, et al
    Cross-resistance to 14-, 15- and 16-membered ring macrolides in Salmonella and Campylobacter.
    J Antimicrob Chemother. 2025;80:1445-1452.
    PubMed     Abstract available
    
    
    April 2025
81. LOCKE JB, Andes D, Flanagan S, Redell M, et al
    Activity of rezafungin against Candida auris.
    J Antimicrob Chemother. 2025 Apr 30:dkaf124. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. FIFER H, Johnson A
    The continuing evolution of antibiotic resistance in Neisseria gonorrhoeae: past, present and future threats to effective treatment.
    J Antimicrob Chemother. 2025 Apr 10:dkaf109. doi: 10.1093.
    PubMed     Abstract available
    
    
    
83. ORTONNE V, Bouvier-Alias M, Vo-Quang E, Cappy P, et al
    Performance evaluation of a fully automated deep sequencing platform for hepatitis B genotyping and resistance testing.
    J Antimicrob Chemother. 2025;80:919-926.
    PubMed     Abstract available
    
    
    
84. KOSTYANEV T, Al-Mir H, Prifti K, Rasmussen LB, et al
    External quality assurance (EQA) network in South and South-East Asia: experience and results from an international EQA programme in One Health sector reference laboratories.
    J Antimicrob Chemother. 2025;80:1037-1046.
    PubMed     Abstract available
    
    
    
85. JAKUBU V, Cechova M, Musilek M, Malisova L, et al
    Amino acid substitutions in PBP3 in Haemophilus influenzae strains, their phenotypic detection and impact on resistance to beta-lactams.
    J Antimicrob Chemother. 2025;80:980-987.
    PubMed     Abstract available
    
    
    
86. OMODING D, Musinguzi N, Boum Y 2nd, Muzoora C, et al
    Subtypes A1 and D, and recombinant HIV-1 natural polymorphisms associated with lenacapavir drug resistance in Uganda.
    J Antimicrob Chemother. 2025;80:955-961.
    PubMed     Abstract available
    
    
    
87. REBELO AR, Bortolaia V, Leekitcharoenphon P, Hansen DS, et al
    One day in Denmark: whole-genome sequence-based analysis of Escherichia coli isolates from clinical settings.
    J Antimicrob Chemother. 2025;80:1011-1021.
    PubMed     Abstract available
    
    
    
88. ZHENG YQ, Li QG, Latge JP, Tang XK, et al
    Potential risk of cross-resistance to voriconazole in HIV/AIDS patients with Talaromyces marneffei infection and the mechanisms of the cross-resistance.
    J Antimicrob Chemother. 2025;80:976-979.
    PubMed     Abstract available
    
    
    
89. ALIDJINOU EK, Coulon P, Tetart M, Guigon A, et al
    Defective HIV-1 DNA pol sequences are not associated with HIV-1 DNA levels and drive most APOBEC-context drug resistance mutations.
    J Antimicrob Chemother. 2025;80:941-946.
    PubMed     Abstract available
    
    
    
90. D'ANTONI ML, Falkard B, Andreatta K, Cox S, et al
    Assessing phenotypic effect of integrase strand-transfer inhibitor (INSTI)-based resistance substitutions associated with failures on cabotegravir.
    J Antimicrob Chemother. 2025;80:962-966.
    PubMed     Abstract available
    
    
    
91. SHU Y, Liu J, Yang C, Li J, et al
    Prevalence of drug resistance mutations in low-level viremia patients under antiretroviral therapy in Southwestern China: a cross-sectional study.
    J Antimicrob Chemother. 2025;80:947-954.
    PubMed     Abstract available
    
    
    March 2025
92. MANCINI S, Greiner M, Egli A, Nolte O, et al
    In vitro susceptibility testing of vancomycin-resistant Enterococcus faecium to fosfomycin.
    J Antimicrob Chemother. 2025 Mar 18:dkaf084. doi: 10.1093.
    PubMed    
    
    
    
93. SCHRODER D, Cherdtrakulkiat T, Doanh LH, Golparian D, et al
    Exceedingly high levels of tetracycline resistance in Neisseria gonorrhoeae in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024-doxycycline post-exposure prophylaxis will unlikely impact gono
    J Antimicrob Chemother. 2025 Mar 18:dkaf066. doi: 10.1093.
    PubMed     Abstract available
    
    
    
94. CINTHI M, Coccitto SN, Simoni S, Gherardi G, et al
    The optrA, cfr(D) and vanA genes are co-located on linear plasmids in linezolid- and vancomycin-resistant enterococcal clinical isolates in Italy.
    J Antimicrob Chemother. 2025 Mar 17:dkaf082. doi: 10.1093.
    PubMed     Abstract available
    
    
    
95. PAGANO L, Fernandez OM
    Clinical aspects and recent advances in fungal diseases impacting human health.
    J Antimicrob Chemother. 2025;80.
    PubMed     Abstract available
    
    
    
96. ARENDRUP MC, Cordonnier C
    Refractory versus resistant invasive aspergillosis.
    J Antimicrob Chemother. 2025;80.
    PubMed     Abstract available
    
    
    
97. WU S, Zhang L, Luo X, Lin C, et al
    In vitro and in vivo antibacterial activity, resistance analysis and molecular docking study of pleuromutilin derivatives against Streptococcus suis.
    J Antimicrob Chemother. 2025 Mar 13:dkaf064. doi: 10.1093.
    PubMed     Abstract available
    
    
    
98. LIU Q, Zhou X, Du Z, Wang X, et al
    Intraventricular injection of eravacycline in the treatment of carbapenem-resistant Acinetobacter baumannii meningitis: a case report.
    J Antimicrob Chemother. 2025 Mar 11:dkaf069. doi: 10.1093.
    PubMed    
    
    
    
99. BRAND C, Newton-Foot M, Grobbelaar M, Whitelaw A, et al
    Antibiotic-induced stress responses in Gram-negative bacteria and their role in antibiotic resistance.
    J Antimicrob Chemother. 2025 Mar 7:dkaf068. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. DING J, Hameed HMA, Long L, Zhang J, et al
     Correlation between rrs gene mutations and amikacin resistance in Mycobacterium abscessus: implications for fitness cost and clinical prevalence.
     J Antimicrob Chemother. 2025;80:746-751.
     PubMed     Abstract available
     
     
     
101. ABDI B, Saliba S, Wirden M, Faycal A, et al
     No virological failure in patients living with HIV with past NNRTI resistance-associated mutations switched to doravirine-containing regimens.
     J Antimicrob Chemother. 2025;80:810-816.
     PubMed     Abstract available
     
     
     
102. KARADOGAN E, Sertcelik A, Dizman GT, Uzar H, et al
     A scoring system to predict resistance to ceftolozane/tazobactam in respiratory isolates of Pseudomonas aeruginosa.
     J Antimicrob Chemother. 2025;80:788-796.
     PubMed     Abstract available
     
     
     
103. WIRDEN M, Abdi B, Lambert-Niclot S, Chaix ML, et al
     Major role of dolutegravir in the emergence of the S147G integrase resistance mutation.
     J Antimicrob Chemother. 2025;80:692-696.
     PubMed     Abstract available
     
     
     
104. CHOGA OT, Lemogang GM, Choga WT, Muzanywa G, et al
     High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in Francistown, Botswana.
     J Antimicrob Chemother. 2025;80:767-776.
     PubMed     Abstract available
     
     
     
105. CLEMENTE T, Diotallevi S, Minisci D, Di Biagio A, et al
     Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry.
     J Antimicrob Chemother. 2025;80:731-737.
     PubMed     Abstract available
     
     
     
106. FAROOQ A, Martens M, Kroemer N, Pfaffendorf C, et al
     Pharmacokinetic/pharmacodynamic analysis of meropenem and fosfomycin combinations in in vitro time-kill and hollow-fibre infection models against multidrug-resistant and carbapenemase-producing Klebsiella pneumoniae.
     J Antimicrob Chemother. 2025;80:701-712.
     PubMed     Abstract available
     
     
     
107. SOULIE C, Agher R, Fauchois A, Abdi B, et al
     Changes in NNRTI use have not altered the ecology of NNRTI resistance over the last 10 years in people with HIV experiencing virological failure on antiretroviral drugs.
     J Antimicrob Chemother. 2025;80:697-700.
     PubMed     Abstract available
     
     
     
108. TOBIN LA, Abu Sabah E, Lebreton F, Myers GSA, et al
     Genomic analysis of early ST32 Acinetobacter baumannii strains recovered in US military treatment facilities reveals distinct lineages and links to the origins of the Tn6168 ampC transposon.
     J Antimicrob Chemother. 2025;80:666-675.
     PubMed     Abstract available
     
     
     
109. MUSHTAQ S, Vickers A, Doumith M, Garello P, et al
     Frequencies and mechanisms of mutational resistance to ceftibuten/avibactam in Enterobacterales.
     J Antimicrob Chemother. 2025;80:645-656.
     PubMed     Abstract available
     
     
     February 2025
110. SERAPIDE F, Serraino R, Spadafora L, Bernardi M, et al
     Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience.
     J Antimicrob Chemother. 2025 Feb 25:dkaf055. doi: 10.1093.
     PubMed     Abstract available
     
     
     
111. LODHIA Z, Costa Da Silva J, Correia C, Cordeiro D, et al
     Surveying genetic markers of antibiotic resistance and genomic background in Chlamydia trachomatis: insights from a multiplex NGS-based approach in clinical strains from Portugal.
     J Antimicrob Chemother. 2025 Feb 17:dkaf036. doi: 10.1093.
     PubMed     Abstract available
     
     
     
112. WERTH BJ, Zhang R, Barreras Beltran IA, Penewit K, et al
     Simulated exposures of oritavancin in in vitro pharmacodynamic models select for methicillin-resistant Staphylococcus aureus with reduced susceptibility to oritavancin but minimal cross-resistance or seesaw effect with other antimicrobials.
     J Antimicrob Chemother. 2025 Feb 12:dkaf042. doi: 10.1093.
     PubMed     Abstract available
     
     
     
113. EDSLEV SM, Aarris M, Nielsen KL, Hertz FB, et al
     rpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis.
     J Antimicrob Chemother. 2025 Feb 6:dkaf035. doi: 10.1093.
     PubMed     Abstract available
     
     
     
114. XING H, Zhang L, Li C, Schwarz S, et al
     Identification of a mepR mutation associated with tigecycline resistance in a clinical Staphylococcus aureus isolate.
     J Antimicrob Chemother. 2025 Feb 6:dkaf034. doi: 10.1093.
     PubMed     Abstract available
     
     
     
115. BIANCO G, Boattini M, Lupo L, Ambretti S, et al
     In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre observational study
     J Antimicrob Chemother. 2025;80:583-592.
     PubMed     Abstract available
     
     
     
116. JO J, Kim SJ, Kwon KT, Ko KS, et al
     Resilience of tigecycline heteroresistance phenotype in Acinetobacter baumannii.
     J Antimicrob Chemother. 2025;80:496-502.
     PubMed     Abstract available
     
     
     
117. CUI XD, Liu SB, Wang RY, He DD, et al
     Investigation on the reversal effect of closantel on colistin resistance in MCR-1 positive Escherichia coli based on dose-response relationship.
     J Antimicrob Chemother. 2025;80:528-537.
     PubMed     Abstract available
     
     
     
118. PAPAIOANNU BORJESSON R, Clemente T, Diotallevi S, Lolatto R, et al
     Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting.
     J Antimicrob Chemother. 2025;80:405-408.
     PubMed     Abstract available
     
     
     
119. TUMBARELLO M, Giuliano G, Criscuolo M, Del Principe MI, et al
     Clinical impact of ceftazidime/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world study.
     J Antimicrob Chemother. 2025;80:386-398.
     PubMed     Abstract available
     
     
     January 2025
120. BITTERMAN R, Awwad A, Darawsha B, Dallashi H, et al
     Ceftaroline versus vancomycin for methicillin-resistant Staphylococcus aureus bacteraemia, a matched cohort study.
     J Antimicrob Chemother. 2025 Jan 28:dkaf009. doi: 10.1093.
     PubMed     Abstract available
     
     
     
121. CADDEY B, Shaukat W, Tang KL, Barkema HW, et al
     Vancomycin-resistant Enterococcus prevalence and its association along the food chain: a systematic review and meta-analysis.
     J Antimicrob Chemother. 2025 Jan 24:dkaf008. doi: 10.1093.
     PubMed     Abstract available
     
     
     
122. 
     Correction to: Synergistic effects of colistin-rifampin-based triple antimicrobial combination therapy against Carbapenem-resistant Pseudomonas aeruginosa: a time-kill assay.
     J Antimicrob Chemother. 2025 Jan 17:dkaf021. doi: 10.1093.
     PubMed    
     
     
     
123. OHEMU GP, Read C, Onwukwe CD, Olorunleke SO, et al
     Educate, Advocate, Act Now: a sustainable approach to combating antimicrobial resistance TODAY.
     J Antimicrob Chemother. 2025 Jan 7:dkae478. doi: 10.1093.
     PubMed     Abstract available
     
     
     
124. MOREY F, Giron-Callejas A, Manzanero R, Urbina A, et al
     Pretreatment and acquired HIV drug resistance in Belize-results of nationally representative surveys, 2021-22.
     J Antimicrob Chemother. 2025;80:292-300.
     PubMed     Abstract available
     
     
     
125. MELLO TP, Ramos LS, Andrade VV, Torres-Santos EC, et al
     Elucidating the augmented resistance profile of Scedosporium/Lomentospora species to azoles in a cystic fibrosis mimic environment.
     J Antimicrob Chemother. 2025;80:106-115.
     PubMed     Abstract available
     
     
     
126. YANXIA S, Xuewei W, Gang L, Wei J, et al
     Analysis on characteristics and multilocus sequence typing of Clostridium perfringens in western China.
     J Antimicrob Chemother. 2025;80:216-226.
     PubMed     Abstract available
     
     
     
127. CHEN S, Shang Y, Zheng J, Huo F, et al
     In vitro monitoring of drug resistance emergence during stepwise induction of bedaquiline and clofazimine, alone and in combination: a phenotypic and genotypic analysis.
     J Antimicrob Chemother. 2025;80:262-269.
     PubMed     Abstract available
     
     
     
128. BALTAS I, Patel T, Soares AL
     Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?
     J Antimicrob Chemother. 2025;80:59-67.
     PubMed     Abstract available
     
     
     
129. HIRABAYASHI A, Yano H, Yahara K, Aoki S, et al
     Emergence of the mobile RND-type efflux pump gene cluster tmexCD1-toprJ1 in Klebsiella pneumoniae clinical isolates in Japan.
     J Antimicrob Chemother. 2025;80:192-199.
     PubMed     Abstract available
     
     
     
130. ANDO N, Mizushima D, Takano M, Mitobe M, et al
     Prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium.
     J Antimicrob Chemother. 2025;80:247-253.
     PubMed     Abstract available
     
     
     
131. ROBERTSON A, Coutinho G, Mantzourani E, Szomolay B, et al
     Over-the-counter antibiotics compromising aminoglycoside activity.
     J Antimicrob Chemother. 2025;80:87-94.
     PubMed     Abstract available
     
     
     
132. PARIONA JGM, Vasquez-Ponce F, Pariona EMM, Sousa-Carmo RR, et al
     Efficacy of meropenem against ceftazidime-avibactam-resistant Klebsiella pneumoniae producing KPC-31, KPC-33, KPC-90, KPC-106 and KPC-114.
     J Antimicrob Chemother. 2025;80:162-168.
     PubMed     Abstract available
     
     
     
133. MARCELIN AG, Soulie C, Wirden M, Barriere G, et al
     Emergent resistance-associated mutations at first- or second-line HIV-1 virologic failure with second-generation InSTIs in two- and three-drug regimens: the Virostar-1 study.
     J Antimicrob Chemother. 2025;80:95-101.
     PubMed     Abstract available
     
     
     December 2024
134. KIM SH, Kim HM, Chung DR, Ko JH, et al
     Synergistic effects of colistin-rifampin-based triple antimicrobial combination therapy against Carbapenem-resistant Pseudomonas aeruginosa: a time-kill assay.
     J Antimicrob Chemother. 2024 Dec 31:dkae466. doi: 10.1093.
     PubMed     Abstract available
     
     
     
135. ERSOY SC, Madrigal SL, Proctor RA, Chambers HF, et al
     NaHCO3 modulates the bla operon and beta-lactam susceptibility in borderline oxacillin-resistant Staphylococcus aureus (BORSA).
     J Antimicrob Chemother. 2024 Dec 20:dkae455. doi: 10.1093.
     PubMed     Abstract available
     
     
     
136. HANAI Y, Matsumoto K, Endo A, Hanawa K, et al
     Treatment success prediction in patients with methicillin-resistant coagulase-negative staphylococci infections, using vancomycin AUC24/MIC ratio: a multicentre retrospective cohort study.
     J Antimicrob Chemother. 2024 Dec 17:dkae442. doi: 10.1093.
     PubMed     Abstract available
     
     
     
137. ASSEFA GM, Roberts JA, Aslan AT, Mohammed SA, et al
     A systematic review and individual bacterial species level meta-analysis of in vitro studies on the efficacy of ceftazidime/avibactam combined with other antimicrobials against carbapenem-resistant Gram-negative bacteria.
     J Antimicrob Chemother. 2024 Dec 17:dkae451. doi: 10.1093.
     PubMed     Abstract available
     
     
     
138. DOELMAN TA, Adriaens N, Westerhuis BM, Bruisten SM, et al
     Phenotypic antibiotic resistance of Mycoplasma genitalium and its variation between different macrolide resistance-associated mutations.
     J Antimicrob Chemother. 2024 Dec 4:dkae430. doi: 10.1093.
     PubMed     Abstract available
     
     
     
139. FIFER H, Doumith M, Rubinstein L, Mitchell L, et al
     Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015-24: an observational analysis.
     J Antimicrob Chemother. 2024;79:3332-3339.
     PubMed     Abstract available
     
     
     
140. STERN A, Henig I, Cohen M, Gur I, et al
     Impact of discontinuing routine fluoroquinolone prophylaxis in neutropenic allogeneic haematopoietic stem cell transplant recipients: an observational study.
     J Antimicrob Chemother. 2024;79:3289-3296.
     PubMed     Abstract available
     
     
     
141. HUANG Y, Liao M, Hu X, Hu H, et al
     Advances in the clinical treatment of multidrug-resistant pathogens using polymyxins.
     J Antimicrob Chemother. 2024;79:3210-3229.
     PubMed     Abstract available
     
     
     
142. ALVAREZ C, Nastro M, Goyheneche B, Potente N, et al
     NDM-5-producing Klebsiella pneumoniae ST258 in a university hospital in Argentina.
     J Antimicrob Chemother. 2024;79:3174-3177.
     PubMed     Abstract available
     
     
     November 2024
143. LEROY AG, Lemenand O, Thibaut S, Coeffic T, et al
     Assessment of co-resistance to antibiotics recommended for acute pyelonephritis among Escherichia coli clinical strains from community- and nursing home-acquired urinary tract infections.
     J Antimicrob Chemother. 2024 Nov 29:dkae431. doi: 10.1093.
     PubMed     Abstract available
     
     
     
144. LIU Q, Li S, Wang X, Lin Y, et al
     Comparative evaluation of eravacycline susceptibility testing methods in 587 clinical carbapenem-resistant Acinetobacter baumannii isolates: broth microdilution, MIC test strip and disc diffusion.
     J Antimicrob Chemother. 2024 Nov 21:dkae426. doi: 10.1093.
     PubMed     Abstract available
     
     
     
145. MCGUIRE E, Ready D, Ellaby N, Potterill I, et al
     A case of penicillin-resistant group B Streptococcus isolated from a patient in the UK.
     J Antimicrob Chemother. 2024 Nov 15:dkae419. doi: 10.1093.
     PubMed     Abstract available
     
     
     
146. QIAN C, Hu P, Guo W, Han Y, et al
     Genome analysis of tigecycline-resistant Acinetobacter baumannii reveals nosocomial lineage shifts and novel resistance mechanisms.
     J Antimicrob Chemother. 2024;79:2965-2974.
     PubMed     Abstract available
     
     
     
147. LODISE TP, Obi EN, Watanabe AH, Yucel E, et al
     Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa.
     J Antimicrob Chemother. 2024;79:2954-2964.
     PubMed     Abstract available
     
     
     
148. PARK J, Lee D, Yi H, Yun CW, et al
     Bacterial persistence to antibiotics activated by tRNA mutations.
     J Antimicrob Chemother. 2024;79:2923-2931.
     PubMed     Abstract available
     
     
     
149. YANG F, Sun X, Fu Y, Zhao F, et al
     High-level ceftriaxone resistance due to transfer of penA allele 60.001 into endemic gonococcal lineages in Hangzhou, China.
     J Antimicrob Chemother. 2024;79:2854-2857.
     PubMed     Abstract available
     
     
     October 2024
150. AVCU G, Erci E, Bilen NM, Ersayoglu I, et al
     Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital.
     J Antimicrob Chemother. 2024 Oct 30:dkae387. doi: 10.1093.
     PubMed     Abstract available
     
     
     
151. STURARO MC, de Souza GHA, Damaceno NDS, Silva ON, et al
     Antimicrobial activity of ceftibuten/polymyxin B combination against polymyxin/carbapenem-resistant Klebsiella pneumoniae.
     J Antimicrob Chemother. 2024 Oct 25:dkae382. doi: 10.1093.
     PubMed     Abstract available
     
     
     
152. GHAHRAMANI A, Naghadian Moghaddam MM, Kianparsa J, Ahmadi MH, et al
     Overall status of carbapenem resistance among clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis.
     J Antimicrob Chemother. 2024 Oct 11:dkae358. doi: 10.1093.
     PubMed     Abstract available
     
     
     
153. YU L, Han X, Zhang W, Fu Y, et al
     The two-component sensor factor envZ influences antibiotic resistance and virulence in the evolutionary dynamics of multidrug-resistant Salmonella enteritidis causing multisite invasive infections.
     J Antimicrob Chemother. 2024 Oct 4:dkae355. doi: 10.1093.
     PubMed     Abstract available
     
     
     
154. SIMJEE S, Weese JS, Singh R, Trott DJ, et al
     Redefining cross-resistance, co-resistance and co-selection: beyond confusion?
     J Antimicrob Chemother. 2024;79:2417-2420.
     PubMed     Abstract available
     
     
     
155. ALIEVA KN, Golikova MV, Zinner SH
     Role of volume and inoculum in MIC assessment: a study with meropenem and Klebsiella pneumoniae.
     J Antimicrob Chemother. 2024;79:2698-2707.
     PubMed     Abstract available
     
     
     
156. HALLIDAY CL, Tay E, Green W, Law D, et al
     In vitro activity of olorofim against 507 filamentous fungi including antifungal drug-resistant strains at a tertiary laboratory in Australia: 2020-2023.
     J Antimicrob Chemother. 2024;79:2611-2621.
     PubMed     Abstract available
     
     
     
157. DAVIN-REGLI A, Pages JM, Vergalli J
     The contribution of porins to enterobacterial drug resistance.
     J Antimicrob Chemother. 2024;79:2460-2470.
     PubMed     Abstract available
     
     
     
158. ZHANG XW, Song JJ, Zeng SH, Huang YL, et al
     Plasmid-mediated azithromycin resistance in non-typhoidal Salmonella recovered from human infections.
     J Antimicrob Chemother. 2024;79:2688-2697.
     PubMed     Abstract available
     
     
     
159. GONZALEZ-PINTO L, Alonso-Garcia I, Blanco-Martin T, Camacho-Zamora P, et al
     Impact of chromosomally encoded resistance mechanisms and transferable beta-lactamases on the activity of cefiderocol and innovative beta-lactam/beta-lactamase inhibitor combinations against Pseudomonas aeruginosa.
     J Antimicrob Chemother. 2024;79:2591-2597.
     PubMed     Abstract available
     
     
     
160. WANG Z, Jiang H, Pang X, Li J, et al
     Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022.
     J Antimicrob Chemother. 2024;79:2575-2585.
     PubMed     Abstract available
     
     
     
161. ESCRIHUELA-VIDAL F, Fernandez-Hidalgo N, Munoz P, Villamarin M, et al
     Infective endocarditis caused by penicillin-resistant viridans group streptococci: a series of nine cases from a Spanish cohort.
     J Antimicrob Chemother. 2024 Oct 1:dkae345. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2024
162. SHAN X, Li C, Zhang L, Zou C, et al
     poxtA amplification and mutations in 23S rRNA confer enhanced linezolid resistance in Enterococcus faecalis.
     J Antimicrob Chemother. 2024 Sep 27:dkae342. doi: 10.1093.
     PubMed     Abstract available
     
     
     
163. CORNU HEWITT B, Bossers A, van Kersen W, de Rooij MMT, et al
     Associations between acquired antimicrobial resistance genes in the upper respiratory tract and livestock farm exposures: a case-control study in COPD and non-COPD individuals.
     J Antimicrob Chemother. 2024 Sep 24:dkae335. doi: 10.1093.
     PubMed     Abstract available
     
     
     
164. YANG W, Li X, Chen J, Zhang G, et al
     Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus.
     J Antimicrob Chemother. 2024 Sep 24:dkae331. doi: 10.1093.
     PubMed     Abstract available
     
     
     
165. DRYDEN M, Corley M, Wright N, Andrewin A, et al
     The United Nations' General Assembly High-Level Meeting on antimicrobial resistance: a joint statement from the Heads of Government and Chief Medical Officers of the United Kingdom's Overseas Territories.
     J Antimicrob Chemother. 2024 Sep 19:dkae330. doi: 10.1093.
     PubMed     Abstract available
     
     
     
166. KARLOWSKY JA, Wise MG, Hackel MA, Six DA, et al
     Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22.
     J Antimicrob Chemother. 2024 Sep 17:dkae329. doi: 10.1093.
     PubMed     Abstract available
     
     
     
167. KRUGER-HAKER H, Kostova V, Hanke D, Kaspar H, et al
     Genetic basis of macrolide resistance in porcine Pasteurella multocida isolates from the German national resistance monitoring program GERM-Vet 2008-2021.
     J Antimicrob Chemother. 2024 Sep 13:dkae316. doi: 10.1093.
     PubMed     Abstract available
     
     
     
168. ABDELALL LM, Nagy YI, Kashef MT
     Restoring vancomycin activity against resistant Enterococcus faecalis using a transcription factor decoy as a vanA operon-inhibitor.
     J Antimicrob Chemother. 2024 Sep 10:dkae320. doi: 10.1093.
     PubMed     Abstract available
     
     
     
169. WIDERSTROM R, Aarris M, Jacobsson S, Stegger M, et al
     Probing fosfomycin's potential: a study on susceptibility testing and resistance in Staphylococcus epidermidis from prosthetic joint infections.
     J Antimicrob Chemother. 2024 Sep 6:dkae312. doi: 10.1093.
     PubMed     Abstract available
     
     
     
170. BOUTZOUKAS AE, Mackow N, Giri A, Komarow L, et al
     Increased mortality in hospital- compared to community-onset carbapenem-resistant enterobacterales infections.
     J Antimicrob Chemother. 2024 Sep 5:dkae306. doi: 10.1093.
     PubMed     Abstract available
     
     
     
171. FABENI L, Armenia D, Abbate I, Gagliardini R, et al
     HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21.
     J Antimicrob Chemother. 2024;79:2152-2162.
     PubMed     Abstract available
     
     
     
172. ARMENIA D, Spagnuolo V, Bellocchi MC, Galli L, et al
     Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry.
     J Antimicrob Chemother. 2024;79:2354-2363.
     PubMed     Abstract available
     
     
     
173. DAVID A, Golparian D, Jacobsson S, Stratton C, et al
     In silico gepotidacin target mining among 33 213 global Neisseria gonorrhoeae genomes from 1928 to 2023 combined with gepotidacin MIC testing of 22 gonococcal isolates with different GyrA and ParC substitutions.
     J Antimicrob Chemother. 2024;79:2221-2226.
     PubMed     Abstract available
     
     
     
174. MAZZITELLI M, Pontillo D, Clemente T, Di Biagio A, et al
     Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry.
     J Antimicrob Chemother. 2024;79:2163-2169.
     PubMed     Abstract available
     
     
     
175. GLEN KA, Lamont IL
     Penicillin-binding protein 3 sequence variations reduce susceptibility of Pseudomonas aeruginosa to beta-lactams but inhibit cell division.
     J Antimicrob Chemother. 2024;79:2170-2178.
     PubMed     Abstract available
     
     
     
176. DIZI ISIK A, Akkoc G, Ergenc Z, Yilmaz S, et al
     The use of fosfomycin in infections caused by multidrug-resistant pathogens, especially pneumonia in children: a five-year retrospective single-centre experience.
     J Antimicrob Chemother. 2024;79:2179-2185.
     PubMed     Abstract available
     
     
     
177. ABOUELHASSAN Y, Nicolau DP, Abdelraouf K
     Defining optimal sulbactam regimens for treatment of Acinetobacter baumannii pneumonia and impact of blaOXA-23 on efficacy.
     J Antimicrob Chemother. 2024;79:2306-2316.
     PubMed     Abstract available
     
     
     August 2024
178. PAPOUSKOVA A, Drabkova Z, Brajerova M, Krutova M, et al
     The circulation of methicillin-resistant Staphylococcus aureus between humans, horses and the environment at the equine clinic.
     J Antimicrob Chemother. 2024 Aug 30:dkae303. doi: 10.1093.
     PubMed     Abstract available
     
     
     
179. COUTO F, Martins I, Vale F, Domingues F, et al
     Insights into macrolide resistance in Arcobacter butzleri: potential resistance mechanisms and impact on bacterial fitness and virulence.
     J Antimicrob Chemother. 2024 Aug 19:dkae287. doi: 10.1093.
     PubMed     Abstract available
     
     
     
180. LUZARRAGA V, Cremniter J, Plouzeau C, Michaud A, et al
     In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates.
     J Antimicrob Chemother. 2024 Aug 10:dkae269. doi: 10.1093.
     PubMed     Abstract available
     
     
     
181. 
     Correction to: Prediction of antimicrobial resistance in Klebsiella pneumoniae using genomic and metagenomic next-generation sequencing data.
     J Antimicrob Chemother. 2024 Aug 6:dkae289. doi: 10.1093.
     PubMed    
     
     
     
182. MEIJS AP, Chaname-Pinedo LE, Deng H, Veldman KT, et al
     Association between antimicrobial usage in livestock and antimicrobial resistance in Escherichia coli isolates from human urinary tract infections in the Netherlands, 2009-2020.
     J Antimicrob Chemother. 2024 Aug 2:dkae268. doi: 10.1093.
     PubMed     Abstract available
     
     
     
183. SCHELLENBERG JJ, Adam HJ, Baxter MR, Karlowsky JA, et al
     Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007-21.
     J Antimicrob Chemother. 2024 Aug 2:dkae272. doi: 10.1093.
     PubMed     Abstract available
     
     
     
184. UNEMO M, Sanchez-Buso L, Golparian D, Jacobsson S, et al
     The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains-phenotypic, genetic and reference genome characterization.
     J Antimicrob Chemother. 2024;79:1885-1899.
     PubMed     Abstract available
     
     
     
185. SOULIE C, Balde A, Fofana D, Charpentier C, et al
     DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirine.
     J Antimicrob Chemother. 2024;79:1974-1984.
     PubMed     Abstract available
     
     
     
186. BUCZKOWSKA M, Chattaway MA, Jenkins C, Hungerford D, et al
     Linking epidemiological and genomic data in cases of enteric fever in England to inform clinical management and public health action.
     J Antimicrob Chemother. 2024;79:1811-1819.
     PubMed     Abstract available
     
     
     
187. LEE R, Nho D, Cho SY, Park S, et al
     Impact of an antimicrobial stewardship programme on antibiotic utilization and resistance burden in patients with acute leukaemia: an 11-year longitudinal cohort study using interrupted time-series analysis.
     J Antimicrob Chemother. 2024;79:1998-2007.
     PubMed     Abstract available
     
     
     
188. ZHANG X, Zeng W, Kong J, Huang Z, et al
     The prevalence and mechanisms of heteroresistance to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae.
     J Antimicrob Chemother. 2024;79:1865-1876.
     PubMed     Abstract available
     
     
     
189. DWIBEDY SK, Padhy I, Panda AK, Mohapatra SS, et al
     Prevalence of polymyxin-resistant bacterial strains in India: a systematic review and meta-analysis.
     J Antimicrob Chemother. 2024;79:1762-1774.
     PubMed     Abstract available
     
     
     
190. YANG Q, Li L, Zhao G, Cui Q, et al
     Characterization of a multiresistance optrA- and lsa(E)-harbouring unconventional circularizable structure in Streptococcus suis.
     J Antimicrob Chemother. 2024 Aug 1:dkae250. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2024
191. THANASAK J, Wongsurawat T, Jenjaroenpun P, Phumthanakorn N, et al
     Characterization of staphylococcal cassette chromosome mec in Staphylococcus haemolyticus ST3 and ST42 isolates from bovine mastitis milk: identification of novel variant in class C1 mec complex.
     J Antimicrob Chemother. 2024 Jul 31:dkae242. doi: 10.1093.
     PubMed     Abstract available
     
     
     
192. HOWARD A, Green PL, Velluva A, Gerada A, et al
     Bayesian estimation of the prevalence of antimicrobial resistance: a mathematical modelling study.
     J Antimicrob Chemother. 2024 Jul 25:dkae230. doi: 10.1093.
     PubMed     Abstract available
     
     
     
193. ZHOU X, Yang M, Chen F, Wang L, et al
     Prediction of antimicrobial resistance in Klebsiella pneumoniae using genomic and metagenomic next-generation sequencing data.
     J Antimicrob Chemother. 2024 Jul 19:dkae248. doi: 10.1093.
     PubMed     Abstract available
     
     
     
194. SHI Q, Ruan Z, Zhang P, Hu H, et al
     Epidemiology of carbapenem-resistant Klebsiella pneumoniae in China and the evolving trends of predominant clone ST11: a multicentre, genome-based study.
     J Antimicrob Chemother. 2024 Jul 13:dkae227. doi: 10.1093.
     PubMed     Abstract available
     
     
     
195. ZHOU H, Buetti N, Perez-Galera S, Bravo-Ferrer J, et al
     Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study.
     J Antimicrob Chemother. 2024 Jul 11:dkae157. doi: 10.1093.
     PubMed     Abstract available
     
     
     
196. SHEEHY J, Scott AP, Henden AS, Kennedy G, et al
     Low rates of complications and beta-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy.
     J Antimicrob Chemother. 2024 Jul 8:dkae209. doi: 10.1093.
     PubMed     Abstract available
     
     
     
197. SWINKELS AF, Berendsen BJA, Fischer EAJ, Zomer AL, et al
     Extended period of selection for antimicrobial resistance due to recirculation of persistent antimicrobials in broilers.
     J Antimicrob Chemother. 2024 Jul 2:dkae213. doi: 10.1093.
     PubMed     Abstract available
     
     
     
198. VALDEZATE S, Medina-Pascual MJ, Villalon P, Garrido N, et al
     Co-occurrence of the cephalosporinase cepA and carbapenemase cfiA genes in a Bacteroides fragilis division II strain, an unexpected finding.
     J Antimicrob Chemother. 2024;79:1683-1687.
     PubMed     Abstract available
     
     
     
199. DAABOUL D, Osman M, Kassem II, Yassine I, et al
     Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco.
     J Antimicrob Chemother. 2024;79:1614-1618.
     PubMed     Abstract available
     
     
     
200. TEYSSOU E, Soulie C, Fauchois A, Palich R, et al
     The RT M184V resistance mutation clearance in the reservoir is mainly related to CD4 nadir and viral load zenith independently of therapeutic regimen type.
     J Antimicrob Chemother. 2024;79:1673-1676.
     PubMed     Abstract available
     
     
     
201. SCHMID PJ, Forstner P, Kittinger C
     Sliding motility of Bacillus cereus mediates vancomycin pseudo-resistance during antimicrobial susceptibility testing.
     J Antimicrob Chemother. 2024;79:1628-1636.
     PubMed     Abstract available
     
     
     
202. IVANOVA M, Ovsepian A, Leekitcharoenphon P, Seyfarth AM, et al
     Azithromycin resistance in Escherichia coli and Salmonella from food-producing animals and meat in Europe.
     J Antimicrob Chemother. 2024;79:1657-1667.
     PubMed     Abstract available
     
     
     
203. CHEN PJ, Tan MC, Huang WC, Hsu SY, et al
     The individual contributions of blaB, blaGOB and blaCME on MICs of beta-lactams in Elizabethkingia anophelis.
     J Antimicrob Chemother. 2024;79:1577-1580.
     PubMed     Abstract available
     
     
     
204. ELBEDIWI M, Rolff J
     Metabolic pathways and antimicrobial peptide resistance in bacteria.
     J Antimicrob Chemother. 2024;79:1473-1483.
     PubMed     Abstract available
     
     
     
205. WIRDEN M, Pouderoux C, Peytavin G, Abdi B, et al
     Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir.
     J Antimicrob Chemother. 2024;79:1706-1707.
     PubMed    
     
     
     
206. CADENAS-JIMENEZ I, Saiz-Escobedo L, Carrera-Salinas A, Camprubi-Marquez X, et al
     Molecular characterization of macrolide resistance in Haemophilus influenzae and Haemophilus parainfluenzae strains (2018-21).
     J Antimicrob Chemother. 2024 Jul 1:dkae214. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2024
207. CHEN PY, Huang YS, Chuang YC, Wang JT, et al
     Implication of genotypes for prognosis of Candida glabrata bloodstream infections.
     J Antimicrob Chemother. 2024 Jun 22:dkae200. doi: 10.1093.
     PubMed     Abstract available
     
     
     
208. WANG P, Liu S, He X, Miao W, et al
     Therapeutic drug monitoring of polymyxin B cerebrospinal fluid concentrations in patients with carbapenem-resistant Gram-negative bacteria-induced central nervous system infection.
     J Antimicrob Chemother. 2024 Jun 13:dkae193. doi: 10.1093.
     PubMed     Abstract available
     
     
     
209. WESTON G, Giri A, Komarow L, Ge L, et al
     Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales.
     J Antimicrob Chemother. 2024 Jun 12:dkae186. doi: 10.1093.
     PubMed     Abstract available
     
     
     
210. CHANCHAITHONG P, Chueahiran S, Pinpimai K, Sroithongkham P, et al
     Chromosomal and plasmid localization of ileS2 in high-level mupirocin-resistant Staphylococcus pseudintermedius and Staphylococcus aureus isolated from canine and feline origins.
     J Antimicrob Chemother. 2024 Jun 12:dkae172. doi: 10.1093.
     PubMed     Abstract available
     
     
     
211. ALTARAWNEH H, Alhomra T, Alharbi M, Fan Y, et al
     Synergistic bactericidal activity of a novel dual beta-lactam combination against methicillin-resistant Staphylococcus aureus.
     J Antimicrob Chemother. 2024 Jun 4:dkae165. doi: 10.1093.
     PubMed     Abstract available
     
     
     
212. RAHMAT ULLAH S, Jamal M, Rahman A, Andleeb S, et al
     Comprehensive insights into Klebsiella pneumoniae: unravelling clinical impact, epidemiological trends and antibiotic-resistance challenges.
     J Antimicrob Chemother. 2024 Jun 4:dkae184. doi: 10.1093.
     PubMed     Abstract available
     
     
     
213. MARURI-ARANSOLO A, Lopez-Causape C, Hernandez-Garcia M, Garcia-Castillo M, et al
     In vitro activity of cefiderocol in Pseudomonas aeruginosa isolates from people with cystic fibrosis recovered during three multicentre studies in Spain.
     J Antimicrob Chemother. 2024;79:1432-1440.
     PubMed     Abstract available
     
     
     
214. LIU M, Wang M, Huang M, Gao Q, et al
     Iron efflux by IetA enhances beta-lactam aztreonam resistance and is linked to oxidative stress through cellular respiration in Riemerella anatipestifer.
     J Antimicrob Chemother. 2024;79:1385-1396.
     PubMed     Abstract available
     
     
     
215. NAVICKAITE I, Holmes H, Dondi L, Randall L, et al
     Occurrence and characterization of rmtB-harbouring Salmonella and Escherichia coli isolates from a pig farm in the UK.
     J Antimicrob Chemother. 2024;79:1329-1336.
     PubMed     Abstract available
     
     
     
216. KOLTE B, Nubel U
     Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.
     J Antimicrob Chemother. 2024;79:1320-1328.
     PubMed     Abstract available
     
     
     
217. WANGCHINDA W, Pogue JM, Thamlikitkul V, Leelawattanachai P, et al
     Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections.
     J Antimicrob Chemother. 2024;79:1372-1379.
     PubMed     Abstract available
     
     
     
218. ZOU C, Xu C, Yu R, Shan X, et al
     Tandem amplification of a plasmid-borne tet(A) variant gene confers tigecycline resistance in Escherichia coli.
     J Antimicrob Chemother. 2024;79:1294-1302.
     PubMed     Abstract available
     
     
     
219. NISSIM Y, LaSala PR, Slain D
     A serial passage experiment to assess the development of resistance to ertapenem and meropenem among Enterobacterales.
     J Antimicrob Chemother. 2024;79:1463-1466.
     PubMed    
     
     
     
220. TOLLEY A, Bansal A, Murerwa R, Howard Dicks J, et al
     Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review.
     J Antimicrob Chemother. 2024;79:1248-1269.
     PubMed     Abstract available
     
     
     May 2024
221. GALAL L, Mohamed HS, Dupont C, Conquet G, et al
     Circulation of hypervirulent carbapenem-resistant Klebsiella pneumoniae in humans and fish in Djibouti.
     J Antimicrob Chemother. 2024 May 22:dkae144. doi: 10.1093.
     PubMed    
     
     
     
222. LEE YL, Wang WY, Ko WC, Hsueh PR, et al
     Global epidemiology and antimicrobial resistance of Enterobacterales harbouring genes encoding OXA-48-like carbapenemases: insights from the results of the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme 2018-2021.
     J Antimicrob Chemother. 2024 May 17:dkae140. doi: 10.1093.
     PubMed     Abstract available
     
     
     
223. MILLS RO, Dadzie I, Le-Viet T, Baker DJ, et al
     Genomic diversity and antimicrobial resistance in clinical Klebsiella pneumoniae isolates from tertiary hospitals in Southern Ghana.
     J Antimicrob Chemother. 2024 May 16:dkae123. doi: 10.1093.
     PubMed     Abstract available
     
     
     
224. HARMER CJ, Nelson MJ, Lebreton F, Lertsethtakarn P, et al
     Distribution and expression of the aac(6')-Im (aacA16) aminoglycoside resistance gene.
     J Antimicrob Chemother. 2024 May 14:dkae136. doi: 10.1093.
     PubMed     Abstract available
     
     
     
225. BUZON-MARTIN L, Navarro-San Francisco C, Fernandez-Regueras M, Sanchez-Gomez L, et al
     Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature.
     J Antimicrob Chemother. 2024;79:1153-1156.
     PubMed     Abstract available
     
     
     
226. PANG X, He Q, Tang K, Huang J, et al
     Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China.
     J Antimicrob Chemother. 2024;79:1142-1152.
     PubMed     Abstract available
     
     
     
227. CHEN GJ, Cheng CY, Yang CJ, Lee NY, et al
     Trends of pre-treatment drug resistance in antiretroviral-naive people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.
     J Antimicrob Chemother. 2024;79:1157-1163.
     PubMed     Abstract available
     
     
     
228. AGHOKENG AF, Ngo-Giang-Huong N, Huynh THK, Dagnra AY, et al
     Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries.
     J Antimicrob Chemother. 2024;79:1164-1168.
     PubMed     Abstract available
     
     
     
229. GALANI I, Souli M, Katsala D, Karaiskos I, et al
     In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece.
     J Antimicrob Chemother. 2024;79:1101-1108.
     PubMed     Abstract available
     
     
     
230. MALLART E, Guerin F, Amoura A, Le Scouarnec M, et al
     Impact of the phenotypic expression of temocillin resistance in Escherichia coli on temocillin efficacy in a murine peritonitis model.
     J Antimicrob Chemother. 2024;79:1051-1059.
     PubMed     Abstract available
     
     
     
231. UNEMO M, Golparian D, Oxelbark J, Kong FYS, et al
     Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea.
     J Antimicrob Chemother. 2024;79:1006-1013.
     PubMed     Abstract available
     
     
     April 2024
232. WANGCHINDA W, Kaye KS, Patel TS, Albin OR, et al
     A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended beta-lactam-resistant Pseudomonas aeruginosa.
     J Antimicrob Chemother. 2024 Apr 6:dkae104. doi: 10.1093.
     PubMed     Abstract available
     
     
     
233. MACFADYEN AC, Paterson GK
     Methicillin resistance in Staphylococcus pseudintermedius encoded within novel staphylococcal cassette chromosome mec (SCCmec) variants.
     J Antimicrob Chemother. 2024 Apr 2:dkae096. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2024
234. HARMER CJ, Cahill SM, Kenyon JJ, Hall RM, et al
     Aminoglycoside resistance genes in early members of the Acinetobacter baumannii ST78A (SMAL, Italian clone) reside in an IS26-bounded island in the chromosome.
     J Antimicrob Chemother. 2024 Mar 26:dkae064. doi: 10.1093.
     PubMed     Abstract available
     
     
     
235. GOLPARIAN D, Bazzo ML, Ahlstrand J, Schorner MA, et al
     Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16.
     J Antimicrob Chemother. 2024 Mar 22:dkae075. doi: 10.1093.
     PubMed     Abstract available
     
     
     
236. PITT-KENDALL R, Sun S, Hughes S, Merrick R, et al
     Investigating the cause of increased tetracycline-resistant Neisseria gonorrhoeae in England, 2016-20.
     J Antimicrob Chemother. 2024 Mar 22:dkae073. doi: 10.1093.
     PubMed     Abstract available
     
     
     
237. TESSIER E, Ruffier d'Epenoux L, Lartigue MF, Chaufour L, et al
     Comparison of the in vitro activities of delafloxacin and comparators against Staphylococcus epidermidis clinical strains involved in osteoarticular infections: a CRIOGO multicentre retrospective study.
     J Antimicrob Chemother. 2024 Mar 20:dkae071. doi: 10.1093.
     PubMed     Abstract available
     
     
     
238. PHILIP A, Oueslati S, Villa F, Pannetier C, et al
     Development of an ultrafast PCR to detect clinically relevant acquired vancomycin-resistance genes from cultured enterococci.
     J Antimicrob Chemother. 2024 Mar 19:dkae062. doi: 10.1093.
     PubMed     Abstract available
     
     
     
239. KITTL S, Brodard I, Tresch M, Perreten V, et al
     Novel tetracycline resistance gene tet(65) located on a multi-resistance Corynebacterium plasmid.
     J Antimicrob Chemother. 2024 Mar 18:dkae066. doi: 10.1093.
     PubMed     Abstract available
     
     
     
240. ANJUM MF, Duggett N, Sheldon E, Sharma M, et al
     Genomics to detect transmission of livestock-associated methicillin-resistant Staphylococcus aureus from UK pigs in abattoirs during slaughter.
     J Antimicrob Chemother. 2024 Mar 5:dkae052. doi: 10.1093.
     PubMed     Abstract available
     
     
     
241. REZZOUG I, Emeraud C, Girlich D, Creton E, et al
     Characterization of VIM-29 and VIM-86, two VIM-1 variants isolated in multidrug-resistant Enterobacterales in France.
     J Antimicrob Chemother. 2024;79:683-685.
     PubMed    
     
     
     February 2024
242. VAN HAL SJ, Jensen SO, Tong SYC, Bentley S, et al
     Unravelling the complex interplay between antibiotic consumption and adaptive changes in methicillin-resistant Staphylococcus aureus.
     J Antimicrob Chemother. 2024 Feb 27:dkae048. doi: 10.1093.
     PubMed     Abstract available
     
     
     
243. JACQUELINE C, Samper-Cativiela C, Monzon Fernandez S, Ugarte-Ruiz M, et al
     Phenotypic and genetic characterization of antimicrobial resistance in Salmonella enterica serovar Choleraesuis isolates from humans and animals in Spain from 2006 to 2021.
     J Antimicrob Chemother. 2024 Feb 16:dkae029. doi: 10.1093.
     PubMed     Abstract available
     
     
     
244. XU Y, Luo X, Yuan B, Liang P, et al
     The pharmacokinetics/pharmacodynamics of ceftazidime/avibactam for central nervous system infections caused by carbapenem-resistant Gram-negatives: a prospective study.
     J Antimicrob Chemother. 2024 Feb 15:dkae035. doi: 10.1093.
     PubMed     Abstract available
     
     
     
245. BRENCIANI A, Cinthi M, Coccitto SN, Massacci FR, et al
     Global spread of the linezolid-resistant Enterococcus faecalis ST476 clonal lineage carrying optrA.
     J Antimicrob Chemother. 2024 Feb 15:dkae039. doi: 10.1093.
     PubMed     Abstract available
     
     
     
246. HELBO T, Boel JB, Bartels MD, Ahlstrom MG, et al
     Carriage of methicillin-resistant Staphylococcus aureus in children <6 years old: a retrospective follow-up study of the natural course and effectiveness of decolonization treatment.
     J Antimicrob Chemother. 2024 Feb 9:dkae036. doi: 10.1093.
     PubMed     Abstract available
     
     
     
247. SOMAJO S, Nilsson F, Ekelund O, Unemo M, et al
     Detection of antimicrobial resistance in <5 h in Neisseria gonorrhoeae isolates using flow cytometry-proof of concept for seven clinically relevant antimicrobials.
     J Antimicrob Chemother. 2024 Feb 9:dkae034. doi: 10.1093.
     PubMed     Abstract available
     
     
     
248. ROY S, Morita D, Bhattacharya S, Dutta S, et al
     Novel sequence type of carbapenem-resistant Acinetobacter pittii ST1451 with enhanced virulence isolated from septicaemic neonates in India.
     J Antimicrob Chemother. 2024 Feb 9:dkae024. doi: 10.1093.
     PubMed     Abstract available
     
     
     
249. ATAMNA A, Yeshurun M, Shargian L, Raanani P, et al
     Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations.
     J Antimicrob Chemother. 2024 Feb 9:dkae038. doi: 10.1093.
     PubMed    
     
     
     
250. MCHUGH MP, Pettigrew KA, Taori S, Evans TJ, et al
     Consideration of within-patient diversity highlights transmission pathways and antimicrobial resistance gene variability in vancomycin-resistant Enterococcus faecium.
     J Antimicrob Chemother. 2024 Feb 7:dkae023. doi: 10.1093.
     PubMed     Abstract available
     
     
     
251. AULICINO PC, Sharma S, Truong K, Kukunoor V, et al
     Variable antiviral activity of islatravir against M184I/V mutant HIV-1 selected during antiretroviral therapy.
     J Antimicrob Chemother. 2024;79:370-374.
     PubMed     Abstract available
     
     
     
252. HU EW, Lu HF, Lin YT, Yang TC, et al
     Modulatory role of SmeQ in SmeYZ efflux pump-involved functions in Stenotrophomonas maltophilia.
     J Antimicrob Chemother. 2024;79:383-390.
     PubMed     Abstract available
     
     
     
253. NDUVA GM, Otieno F, Kimani J, Sein Y, et al
     Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986-2020.
     J Antimicrob Chemother. 2024;79:287-296.
     PubMed     Abstract available
     
     
     
254. FERRARIS L, Delannoy J, Mazuet C, Diancourt L, et al
     Clostridium neonatale antimicrobial susceptibility, genetic resistance determinants, and genotyping: a multicentre spatiotemporal retrospective analysis.
     J Antimicrob Chemother. 2024;79:271-279.
     PubMed     Abstract available
     
     
     
255. HOSAKA Y, Muraki Y, Kajihara T, Kawakami S, et al
     Antimicrobial use and combination of resistance phenotypes in bacteraemic Escherichia coli in primary care: a study based on Japanese national data in 2018.
     J Antimicrob Chemother. 2024;79:312-319.
     PubMed     Abstract available
     
     
     January 2024
256. FINDLAY J, Bianco G, Boattini M, Nordmann P, et al
     In vivo development of cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii associated with the downregulation of a TonB-dependent siderophore receptor, PiuA.
     J Antimicrob Chemother. 2024 Jan 31:dkae018. doi: 10.1093.
     PubMed    
     
     
     
257. WASAN H, Reeta KH, Gupta YK
     Strategies to improve antibiotic access and a way forward for lower middle-income countries.
     J Antimicrob Chemother. 2024;79:1-10.
     PubMed     Abstract available
     
     
     
258. RITCHIE G, Chorlton SD, Matic N, Bilawka J, et al
     WGS of a cluster of MDR Shigella sonnei utilizing Oxford Nanopore R10.4.1 long-read sequencing.
     J Antimicrob Chemother. 2024;79:55-60.
     PubMed     Abstract available
     
     
     
259. QI Q, Ghaly TM, Rajabal V, Gillings MR, et al
     Dissecting molecular evolution of class 1 integron gene cassettes and identifying their bacterial hosts in suburban creeks via epicPCR.
     J Antimicrob Chemother. 2024;79:100-111.
     PubMed     Abstract available
     
     
     December 2023
260. GILL CM, Santini D, Nicolau DP
     In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity.
     J Antimicrob Chemother. 2023 Dec 28:dkad396. doi: 10.1093.
     PubMed     Abstract available
     
     
     
261. XU C, Li Y, Li Y, Huang L, et al
     Characterization of an ST38 carbapenem-resistant and highly virulent Escherichia coli carrying conjugatively transferable ColV virulence-resistance and blaNDM-5-positive resistance plasmids.
     J Antimicrob Chemother. 2023 Dec 28:dkad403. doi: 10.1093.
     PubMed     Abstract available
     
     
     
262. MASSACCI FR, Cucco L, Paniccia M, Luppi A, et al
     Streptococcus suis serotype 9 in Italy: genomic insights into high-risk clones with emerging resistance to penicillin.
     J Antimicrob Chemother. 2023 Dec 28:dkad395. doi: 10.1093.
     PubMed     Abstract available
     
     
     
263. ZHAO M, He S, Wen R, Li C, et al
     Membrane vesicles derived from Enterococcus faecalis promote the co-transfer of important antibiotic resistance genes located on both plasmids and chromosomes.
     J Antimicrob Chemother. 2023 Dec 18:dkad381. doi: 10.1093.
     PubMed     Abstract available
     
     
     
264. ERTL NG, Anderson TK, Pardo CJ, Maidment TI, et al
     Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia.
     J Antimicrob Chemother. 2023 Dec 15:dkad373. doi: 10.1093.
     PubMed    
     
     
     
265. SHENG Q, Wang N, Zhou Y, Deng X, et al
     A new function of thymol nanoemulsion for reversing colistin resistance in Salmonella enterica serovar Typhimurium infection.
     J Antimicrob Chemother. 2023;78:2983-2994.
     PubMed     Abstract available
     
     
     
266. DJIYOU ABD, Penda CI, Madec Y, Ngondi GD, et al
     Prevalence of HIV drug resistance among adolescents receiving ART in Cameroon with low- or high-level viraemia.
     J Antimicrob Chemother. 2023;78:2938-2942.
     PubMed     Abstract available
     
     
     
267. UNO S, Gatanaga H, Hayashida T, Imahashi M, et al
     Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective study.
     J Antimicrob Chemother. 2023;78:2859-2868.
     PubMed     Abstract available
     
     
     
268. MACGOWAN AP, Attwood MLG, Noel AR, Barber R, et al
     Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistance.
     J Antimicrob Chemother. 2023;78:2869-2877.
     PubMed     Abstract available
     
     
     November 2023
269. JIANG N, Chen H, Cheng L, Fu Q, et al
     Genomic analysis reveals the population structure and antimicrobial resistance of avian Pasteurella multocida in China.
     J Antimicrob Chemother. 2023 Nov 29:dkad365. doi: 10.1093.
     PubMed     Abstract available
     
     
     
270. BOU-ANTOUN S, Rokadiya S, Ashiru-Oredope D, Demirjian A, et al
     COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.
     J Antimicrob Chemother. 2023;78.
     PubMed     Abstract available
     
     
     
271. LEFRANC M, Accoceberry I, Fitton-Ouhabi V, Biteau N, et al
     Rapamycin and caspofungin show synergistic antifungal effects in caspofungin-susceptible and caspofungin-resistant Candida strains in vitro.
     J Antimicrob Chemother. 2023 Nov 22:dkad359. doi: 10.1093.
     PubMed     Abstract available
     
     
     
272. NING YT, Sun TS, Dai RC, Luo ZY, et al
     Emergence of multiple fluconazole-resistant Candida parapsilosis sensu stricto clones with persistence and transmission in China.
     J Antimicrob Chemother. 2023 Nov 22:dkad356. doi: 10.1093.
     PubMed     Abstract available
     
     
     
273. DAI X, Sun J, Zhao W, Wang J, et al
     Emergence of a novel ISS1N-optrA-carrying transposon within an integrative and conjugative element from Streptococcus parasuis.
     J Antimicrob Chemother. 2023 Nov 15:dkad347. doi: 10.1093.
     PubMed     Abstract available
     
     
     
274. LODISE TP, Yucel E, Obi EN, Watanabe AH, et al
     Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant Gram-negative infections who received targeted treatment with a newer beta-lactam or beta-lactam/beta-lactamase inhib
     J Antimicrob Chemother. 2023 Nov 14:dkad351. doi: 10.1093.
     PubMed     Abstract available
     
     
     
275. LI J, Song Y, Deng J, Wang Z, et al
     Deciphering the pivotal role of people with high-frequency occupational animal exposure in antibiotic resistance transmission between humans and animals.
     J Antimicrob Chemother. 2023 Nov 7:dkad307. doi: 10.1093.
     PubMed     Abstract available
     
     
     
276. LI M, Song C, Hu J, Dong A, et al
     Impact of pretreatment low-abundance HIV-1 drug resistance on virological failure after 1 year of antiretroviral therapy in China.
     J Antimicrob Chemother. 2023;78:2743-2751.
     PubMed     Abstract available
     
     
     
277. FUNICIELLO E, Mula J, Mignone F, Silvestro E, et al
     Plasmatic and CSF concentrations of cefiderocol in an infant with extensively drug-resistant Pseudomonas aeruginosa meningoencephalitis.
     J Antimicrob Chemother. 2023;78:2776-2778.
     PubMed    
     
     
     October 2023
278. TRUSWELL A, Lee ZZ, Stegger M, Blinco J, et al
     Augmented surveillance of antimicrobial resistance with high-throughput robotics detects transnational flow of fluoroquinolone-resistant Escherichia coli strain into poultry.
     J Antimicrob Chemother. 2023 Oct 21:dkad323. doi: 10.1093.
     PubMed     Abstract available
     
     
     
279. CALADO NOGUEIRA DE MOURA V, Nguyen MH, Hunkins JJ, Daley CL, et al
     In vitro susceptibility patterns for slowly growing non-tuberculous mycobacteria in the USA from 2018 to 2022.
     J Antimicrob Chemother. 2023 Oct 21:dkad317. doi: 10.1093.
     PubMed     Abstract available
     
     
     
280. LEE SY, Gill CM, Nicolau DP
     Activity of novel beta-lactam/beta-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa.
     J Antimicrob Chemother. 2023 Oct 16:dkad225. doi: 10.1093.
     PubMed     Abstract available
     
     
     
281. CINTHI M, Coccitto SN, Simoni S, Zeni G, et al
     Characterization of a non-functional erm(T) gene in a clinical Enterococcus faecium strain.
     J Antimicrob Chemother. 2023 Oct 14:dkad321. doi: 10.1093.
     PubMed    
     
     
     
282. HALLIDAY C, Kim HY, Tay E, Chen SCA, et al
     Exploring synergy between azole antifungal drugs and statins for Candida auris.
     J Antimicrob Chemother. 2023 Oct 12:dkad303. doi: 10.1093.
     PubMed     Abstract available
     
     
     
283. PICCICA M, Spinicci M, Botta A, Bianco V, et al
     Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.
     J Antimicrob Chemother. 2023 Oct 9:dkad298. doi: 10.1093.
     PubMed     Abstract available
     
     
     
284. CHEN Y, Yong M, Li M, Si Z, et al
     A hydrophilic polyimidazolium antibiotic targeting the membranes of Gram-negative bacteria.
     J Antimicrob Chemother. 2023;78:2581-2590.
     PubMed     Abstract available
     
     
     
285. MARUAPULA D, Moraka NO, Bareng OT, Mokgethi PT, et al
     Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use.
     J Antimicrob Chemother. 2023;78:2489-2495.
     PubMed     Abstract available
     
     
     September 2023
286. 
     Correction to: Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species.
     J Antimicrob Chemother. 2023 Sep 14:dkad282. doi: 10.1093.
     PubMed    
     
     
     
287. JAHA B, Schenkel CD, Jorimann L, Huber M, et al
     Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018.
     J Antimicrob Chemother. 2023;78:2323-2334.
     PubMed     Abstract available
     
     
     
288. VAN HAL SJ, Whiley DM, Le T, Ray S, et al
     Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype.
     J Antimicrob Chemother. 2023;78:2203-2208.
     PubMed     Abstract available
     
     
     July 2023
289. BENDER JK, Baufeld E, Becker K, Claus H, et al
     CHROMAgar LIN-R as an efficient screening tool to assess the prevalence of linezolid-resistant enterococci in German hospital patients-a multicentre study approach, 2021-2022.
     J Antimicrob Chemother. 2023 Jul 20:dkad218. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2023
290. SIMJEE S, Tice G
     The risk-benefit balance of resistance to ionophores in Enterococcus faecium and Enterococcus faecalis for ionophore coccidiostats in broiler chickens.
     J Antimicrob Chemother. 2023 Jun 9:dkad183. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.